![Pablo Cironi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pablo Cironi
Direktor/Vorstandsmitglied bei
Minoryx Therapeutics SL
Profil
Pablo Cironi is currently the Director of Life Science Investment at Caixa Capital Risc SGEIC SA, Director at Medlumics SL, Director at Minoryx Therapeutics SL, Director at Aelix Therapeutics SL, Director at GlyCardial Diagnostics SL, and Director at Iproteos SL.
He previously worked as a Director at Sanifit Therapeutics SA, AptaTargets SL, SpliceBio SL, Technology Development Manager at Fundación Botín, and Head of the Technology & Business Dev Office at Centre For Genomic Regulation.
Dr. Cironi holds a doctorate degree from the University of Barcelona in 2004, a graduate degree from Universidad de Buenos Aires in 2000, and a doctorate degree from Harvard Medical School in 2009.
Aktive Positionen von Pablo Cironi
| Unternehmen | Position | Beginn |
|---|---|---|
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 01.07.2019 |
Medlumics SL
 Medlumics SL Medical SpecialtiesHealth Technology Provides medical imaging diagnostics services | Direktor/Vorstandsmitglied | 01.02.2019 |
Aelix Therapeutics SL
 Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection | Direktor/Vorstandsmitglied | 01.07.2019 |
Iproteos SL
 Iproteos SL Miscellaneous Commercial ServicesCommercial Services Engages in research and development for schizophrenia treatment | Direktor/Vorstandsmitglied | - |
GlyCardial Diagnostics SL
 GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | 01.08.2019 |
Caixa Capital Risc SGEIC SA
 Caixa Capital Risc SGEIC SA Investment ManagersFinance Caixa Capital Risc invests in startup companies located in Europe and North America, primarily in Spain and Portugal. The firm focuses on information technology, life sciences, and industrial technologies sector. It provides equity and loan financing for early and growth stage transactions. It acts as a lead investor and is open to co-invest with other general partners | Private Equity Investor | 01.09.2018 |
Ehemalige bekannte Positionen von Pablo Cironi
| Unternehmen | Position | Ende |
|---|---|---|
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | 01.01.2022 |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Direktor/Vorstandsmitglied | 01.01.2022 |
AptaTargets SL
 AptaTargets SL Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses in developing therapeutic applications based on aptamer technology | Direktor/Vorstandsmitglied | 01.09.2020 |
| ░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Pablo Cironi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
University of Barcelona
 University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caixa Capital Risc SGEIC SA
Caixa Capital Risc SGEIC SA Investment ManagersFinance Caixa Capital Risc invests in startup companies located in Europe and North America, primarily in Spain and Portugal. The firm focuses on information technology, life sciences, and industrial technologies sector. It provides equity and loan financing for early and growth stage transactions. It acts as a lead investor and is open to co-invest with other general partners | Finance |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medlumics SL
Medlumics SL Medical SpecialtiesHealth Technology Provides medical imaging diagnostics services | Health Technology |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Fundación Botín | |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection | Health Technology |
Iproteos SL
Iproteos SL Miscellaneous Commercial ServicesCommercial Services Engages in research and development for schizophrenia treatment | Commercial Services |
AptaTargets SL
AptaTargets SL Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses in developing therapeutic applications based on aptamer technology | Health Technology |
GlyCardial Diagnostics SL
GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Centre For Genomic Regulation |
